TH82508B - Crystal form of 2- (3- fluoro-4-hydroxyphenyl) -7-vinyl-1,3-benzosazol-5-all - Google Patents

Crystal form of 2- (3- fluoro-4-hydroxyphenyl) -7-vinyl-1,3-benzosazol-5-all

Info

Publication number
TH82508B
TH82508B TH601000974A TH0601000974A TH82508B TH 82508 B TH82508 B TH 82508B TH 601000974 A TH601000974 A TH 601000974A TH 0601000974 A TH0601000974 A TH 0601000974A TH 82508 B TH82508 B TH 82508B
Authority
TH
Thailand
Prior art keywords
benzosazol
hydroxyphenyl
fluoro
vinyl
approximately
Prior art date
Application number
TH601000974A
Other languages
Thai (th)
Other versions
TH82508A (en
Inventor
ทาดายอน และคณะ นายอับดอลซมัด
Original Assignee
ไวเอ็ธ
Filing date
Publication date
Application filed by ไวเอ็ธ filed Critical ไวเอ็ธ
Publication of TH82508A publication Critical patent/TH82508A/en
Publication of TH82508B publication Critical patent/TH82508B/en

Links

Abstract

การประดิษฐ์ในที่นี้ถูกควบคุมไปที่รูปแบบผลึกของสารประกอบของน้ำโมเลกุลเดียวและ สารประกอบที่ขจัดน้ำออกของ 2-(3-ฟลูออโร-4-ไฮดรอกซีฟีนิล)-7-ไวนิล-1,3-เบนโซซาซอล-5-ออล ตัว ทำห้กลุ่มเซลล์ที่รับการกระตุ้นของเอสโตรเจนเบาบางลง มีประโยชน์ในการรักษา (ตัวอย่างเช่น) โรคที่ เกี่ยวข้องกับระดับของเอสโตรเจนที่ผิดปกติ The invention here was directed to the crystalline form of a compound of a single molecule of water and Compounds that dehydrate 2- (3-fluoro-4-hydroxyphenyl) -7-vinyl-1,3-benzosazol-5-All A-stimulated cell agent. Estrogen is thinned. Useful in treatment (For example) a disease associated with abnormal levels of estrogen.

Claims (4)

1. สารประกอบที่เป็นสารประกอบของน้ำโมเลกุลเดียวของ 2-(3-ฟลูออโร-4-ไฮดรอกซีฟีนิล)-7- ไวนิล-1,3-เบนโซซาซอล-5-ออล1. a compound that is a compound of a single molecule of water. 2- (3- fluoro-4-hydroxyphenyl) -7-vinyl-1,3-benzosazol-5-all 2. สารประกอบของน้ำโมเลกุลเดียวของข้อถือสิทธิที่ 1 ที่มีรูปแบบการหักเหของผงละเอียดแสง เอ็กซ์เรย์ที่ประกอบด้วยจุดสูงสุด (ในแง่ของ 2เธตา) ที่ประมาณ 9.2 ํ และประมาณ 12.2 ํ2. A water-based compound of claim 1 with a refractive pattern of light-fine powder. An X-ray consisting of a peak (in terms of 2 th) at approximately 9.2 ํ and approximately 12.2 ํ. 3. สารประกอบของน้ำโมเลกุลเดียวของข้อถือสิทธิที่ 1 ที่มีรูปแบบการหักเหของผงละเอียดแสง เอ็กซ์เรย์ที่ประกอบด้วยจุดสูงสุด (ในเง่ของ 2เธตา) ที่ประมาณ 9.2 ํ ประมาณ 12.2 ํ และประมาณ 15.2 ํ3. A water-based compound of claim 1 with a refractive pattern of light-fine powder. An X-ray consisting of a peak (in the money of 2 threads) at approximately 9.2 °, approximately 12.2 ° and approximately 15.2 °. 4. สาร4. Substances
TH601000974A 2006-03-06 Crystal form of 2- (3- fluoro-4-hydroxyphenyl) -7-vinyl-1,3-benzosazol-5-all TH82508B (en)

Publications (2)

Publication Number Publication Date
TH82508A TH82508A (en) 2007-01-18
TH82508B true TH82508B (en) 2007-01-18

Family

ID=

Similar Documents

Publication Publication Date Title
AR122395A2 (en) CRYSTALLINE FORMS OF 5-CHLORO-N2-(2-ISOPROPOXY-5-METHYL-4-PIPERIDIN-4-IL-PHENYL)-N4-[2-(PROPAN-2-SULFONYL)-PHENYL]-PYRIMIDIN-2,4 -DIAMINE
CL2007002169A1 (en) COMPOUNDS DERIVED FROM N- (AMINO-HETEROARIL) -1H-INDOL-2-CARBOXAMIDS; PREPARATION PROCEDURE; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND TO PREVENT OR TREAT INFLAMMATION, UROLOGICAL DISORDERS, GASTROINTESTINE
CL2007003202A1 (en) COMPOUNDS DERIVED FROM ESPIROINDOLINONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CELL PROLIFERATION DISORDERS.
CL2007002018A1 (en) COMPOUNDS DERIVED FROM SUBSTITUTED ISOXAZOLINS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND FOR THE TREATMENT OF A DISEASE CAUSED BY AN INCREASE IN THE CELL PROLIFERATION.
CL2012000033A1 (en) Compounds n- (3- (4as, 7as) -2-amino-4a, 5,7,7a-tetrahydro-4h-furo [3,4-d] [1,3] thiazin-7a-yl) -4- fluorophenyl) -5-fluoropiconylamide, bace inhibitor; pharmaceutical composition comprising them, use of the compound for the treatment of Alzheimer's disease.
CL2007002128A1 (en) DERIVATIVES OF N'-CIANO-N-HALOGENOALQUIL-IMIDAMIDA; PROCEDURE FOR THE PREPARATION OF SUCH COMPOUND; PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT; AND USE OF THE COMPOUND TO COMBAT ANIMAL PARASITES.
CL2007003244A1 (en) COMPOUNDS DERIVED FROM PIRIMIDO [5,4-D] [2] BENZAZEPINA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CANCER.
TR201907804T4 (en) Apaf-1 inhibitor compounds.
WO2008101682A3 (en) Iminipyridine derivatives and their uses as microbiocides
CL2009000394A1 (en) Compounds derived from substituted n- (1h-indazol-5-yl) pyrrolidin-3-carboxamide, erk inhibitors; pharmaceutical composition; and its use in the treatment of cancer.
CL2007001881A1 (en) COMPOUNDS DERIVED FROM IMIDAZOPIRIMIDINE; PROCESS TO PREPARE THE COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE PREVENTION AND / OR TREATMENT OF COGNITIVE DISORDERS.
CL2008001049A1 (en) COMPOUNDS DERIVED FROM SUBSTITUTED BENZAMIDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF DIABETES, INTOLERANCE TO GLUCOSE, DISLIPIDEMIA, HYPERTENSION, OBESITY.
BRPI0910182B8 (en) compound of formula (I), pharmaceutical composition and use of a compound
CL2008000946A1 (en) COMPOUNDS DERIVED FROM PIRROLOPIRIMIDINA, INHIBITORS OF CIANASA JAK3; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF REPLACEMENT OF TRANSPLANTS, AUTOIMMUN DISEASES
EA201100503A1 (en) GLUCOSIDE DERIVATIVES AND THEIR APPLICATIONS
PE20120083A1 (en) MONOTOSILATE SALT OF THE COMPOUND 2-METHYL-2- [4- (3-METHYL-2-OXO-8-QUINOLIN-3-IL-2, 3-DIHYDRO-IMIDAZO- [4,5-C] -QUINOLIN-1- IL) -PHENYL] -PROPIONITRILE IN ITS CRYSTALLINE FORM A
SV2009002865A (en) USE OF OXAZOLIDINONES FOR THE TREATMENT AND PROFILAXIS OF MICROANGIOPATIAS
DK2020996T3 (en) Methods and compositions for the treatment of haematological diseases
MY151295A (en) Pyrimidyl indoline compound
EA200802329A1 (en) TRIAZOLE DERIVATIVES II
WO2009098458A3 (en) Difluorobiphenylamide derivatives for the treatment of ocular hypertension
EA200900913A1 (en) TRIAZOLE DERIVATIVE AS A HSP90 INHIBITOR
NZ593877A (en) Quinazolinone derivatives useful as vanilloid antagonists
WO2008077885A3 (en) 2- [(phenylamino) -pyrimidin-4ylamin0] -cyclopentane carboxamide derivatives and related compounds as inhibitors of kinases of the cell cycle for the treatment of cancer
CL2007003643A1 (en) PHARMACEUTICAL COMPOSITION OF AZIMILIDINE THAT INCLUDES 0.5% TO APPROXIMATELY 2.5% (W / W) OF WATER; AND USE FOR THE TREATMENT OF CARDIAC ARRITMIAS.